Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 09, 2019

SELL
$8.12 - $15.72 $6.35 Million - $12.3 Million
-782,189 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$15.58 - $20.01 $329,999 - $423,831
21,181 Added 2.78%
782,189 $12.3 Million
Q4 2018

Feb 07, 2019

BUY
$14.59 - $23.84 $1.11 Million - $1.81 Million
75,980 Added 11.09%
761,008 $11.7 Million
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $2.68 Million - $3.26 Million
127,215 Added 22.81%
685,028 $14.8 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $84,353 - $124,291
5,030 Added 0.91%
557,813 $13.6 Million
Q1 2018

May 14, 2018

BUY
$16.68 - $22.07 $2.83 Million - $3.75 Million
169,808 Added 44.34%
552,783 $9.45 Million
Q4 2017

Feb 08, 2018

SELL
$11.23 - $19.1 $14,026 - $23,855
-1,249 Reduced 0.33%
382,975 $7.26 Million
Q3 2017

Nov 07, 2017

BUY
$15.41 - $32.17 $66,263 - $138,331
4,300 Added 1.13%
384,224 $6.76 Million
Q2 2017

Aug 18, 2017

BUY
N/A
379,924
379,924 $12.6 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.